AdAlta Limited

ASX (AUD): AdAlta Limited (1AD)

Last Price

0.015

Today's Change

0.00 (0.00%)

Day's Change

0.00 - 0.00

Trading Volume

0

Profile
1AD

Exchange:  Australian Securities Exchange Australian Securities Exchange

Currency:  AUD AUD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Dr. Timothy Charles Oldham B.Sc., BSc(Hons), L.L.B., LLB(Hons), Ph.D. Dr. Timothy Charles Oldham B.Sc., BSc(Hons), L.L.B., LLB(Hons), Ph.D.

Full Time Employees:  9 9

IPO Date:  2016-08-22 2016-08-22

CIK: 

ISIN:  AU0000001AD2 AU0000001AD2

CUSIP:  Q0101X107 Q0101X107

Beta:  0.61 0.61

Last Dividend:  0.00 0.00

Dcf Diff:  0.02 0.02

Dcf:  0.00 0.00

Description

AdAlta Limited, a clinical stage biotechnology company, discovers and develops protein therapeutics in Australia. The company's lead i-body drug candidate includes AD-214, which is in Phase I clinical trials for the treatment of idiopathic pulmonary fibrosis and other fibrotic diseases. It has collaborative partnerships with GE Healthcare to discover i-bodies that bind to granzyme B; and Carina Biotech Pty Ltd. to develop CAR-T cell products against various solid tumor antigens. AdAlta Limited was incorporated in 2006 and is headquartered in Bundoora, Australia.

Address

Shop 14 330 Collins St,
Melbourne, VICTORIA 3083, AU

61394795159

http://adalta.com.au

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment